sharecast

{{ storiesRelated.title }}

Full List Of Stories
23 Jun
ep copa mundialfutbolrusiafifa 18
World Cup preview: England v Panama, Japan v Senegal, Poland v Colombia

England are back in action on Sunday, facing off against shock Central American qualifiers Panama who looked off the pace in their opening 3-0 loss to Belgium.

22 Jun
opec
Commodities: WTI surges even as OPEC signals increased output

A big bounce in crude oil futures drove a small bounce in the larger commodities complex at the end of the week.

22 Jun
deal dl contract handshake acquisition
MPAC Group appoints Will Wilkins as group finance director

Global packaging solutions company MPAC Group on Friday appointed Will Wilkins as group finance director with immediate effect, in order to replace Jim Haughey.

22 Jun
ep copa mundialfutbolrusiafifa 18
World Cup preview: Belgium v Tunisia, South Korea v Mexico, Germany v Sweden

England’s group-mates Belgium and Tunisia are back in action on Saturday as Germany aim to return to winning ways after their shock loss against Mexico.

22 Jun
ep aston martin db11
Aston Martin preparing discounted customer share offering for Autumn float

Luxury car-maker Aston Martin intends to hand millions of pounds to wealthy customers through a London listing expected to value the company at up to £5bn, according to reports on Friday.

22 Jun
Coal mine, mining
Edenville rallies on World Bank funding win

Edenville Energy's shares climbed off their all-time low after the coal miner secured $455m of World Bank funding for its Zambia-Tanzania-Kenya power transition line.

22 Jun
pharma, biotech, drugs, lab, gsk, glaxo, trials,  clinical
Synairgen lung disease drug 'well tolerated' in phase II trial

Respiratory drug discovery and development company Synairgen on Friday released interim data from the phase II trial of its lead drug, SNG001, which showed that it is being “well tolerated”.